Citius Pharmaceuticals, Inc.
CTXR
$0.58
-$0.02-3.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 17.01M | 4.59M | 7.72M | 4.25M | 6.09M |
| Total Receivables | 686.20K | 1.08M | 4.05M | -- | -- |
| Inventory | 22.63M | 22.66M | 22.64M | 22.29M | 17.21M |
| Prepaid Expenses | 3.01M | 3.36M | 3.54M | 1.40M | 1.31M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 43.33M | 31.69M | 37.95M | 27.93M | 24.61M |
|
|
|||||
| Total Current Assets | 43.33M | 31.69M | 37.95M | 27.93M | 24.61M |
| Net Property, Plant & Equipment | 753.00K | 794.50K | 835.20K | 818.70K | 880.70K |
| Long-term Investments | 9.35M | 9.35M | 9.35M | 9.35M | 9.35M |
| Goodwill | 9.35M | 9.35M | 9.35M | 9.35M | 9.35M |
| Total Other Intangibles | 88.79M | 90.51M | 92.23M | 92.80M | 92.80M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 38.10K | 207.30K | 38.10K | 38.10K | 38.10K |
| Total Assets | 142.26M | 132.54M | 140.39M | 130.94M | 127.68M |
|
|
|||||
| Total Accounts Payable | 8.04M | 9.45M | 11.02M | 13.69M | 10.09M |
| Total Accrued Expenses | 27.79M | 27.74M | 7.79M | 7.48M | 12.23M |
| Short-term Debt | -- | -- | 1.00M | 1.00M | 1.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 176.20K | 171.50K | 148.00K | 88.30K | 114.70K |
| Total Finance Division Other Current Liabilities | 15.65M | 17.65M | 18.25M | 22.65M | 28.40M |
| Total Other Current Liabilities | 15.65M | 17.65M | 18.25M | 22.65M | 28.40M |
| Total Current Liabilities | 51.65M | 55.02M | 38.21M | 44.91M | 51.84M |
|
|
|||||
| Total Current Liabilities | 51.65M | 55.02M | 38.21M | 44.91M | 51.84M |
| Long-Term Debt | 6.41M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 1.00M | 1.00M | 1.00M |
| Capital Leases | 590.80K | 636.70K | 681.60K | 724.90K | 767.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.70M | 7.80M | 8.04M | 7.77M | 7.51M |
| Total Liabilities | 66.35M | 63.46M | 46.92M | 53.41M | 60.12M |
|
|
|||||
| Common Stock & APIC | 343.73M | 329.80M | 326.98M | 306.35M | 295.90M |
| Retained Earnings | -277.12M | -268.26M | -247.02M | -238.80M | -230.84M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 66.61M | 61.54M | 79.96M | 67.55M | 65.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 66.61M | 61.54M | 79.96M | 67.55M | 65.06M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 9.30M | 7.54M | 13.51M | 9.98M | 2.50M |
| Total Equity | 75.91M | 69.08M | 93.47M | 77.53M | 67.56M |
|
|
|||||